Federal prosecutors in Oregon have charged two Pakistani nationals in separate schemes accused of bilking Medicare and other programs out of roughly $17 million, part of a nationwide enforcement sweep tied to 455 defendants and more than $6.5 billion in alleged false claims.
Two men were arrested in the District of Oregon after authorities say one ran a lab billing Medicare Advantage plans for genetic tests that were never validly ordered, and the other falsified sleep study records. Jahangeer Ali, 34, is identified as the owner of Oregon Clinical Laboratory and is accused of submitting up to $15 million in fraudulent genetic testing claims. Mehrdad Gerami, 67, is accused of fabricating sleep study results through Coastal Diagnostic Testing Group and Coastal Diagnostic offices.
The arrests come amid an aggressive push from the current administration to root out healthcare fraud, a campaign that has suspended or revoked billing privileges for thousands of providers. Officials say these actions are meant to protect taxpayers and the integrity of federal programs that serve seniors, veterans, and low-income families. The cases are meant to show that enforcement is no longer lax or compartmentalized.
Federal investigators say Ali billed Medicare Advantage plans for genetic tests clinics and doctors told investigators they never ordered. Gerami allegedly claimed sleep studies were done at his facilities when, officials say, those studies either took place somewhere else or never happened. Together, the alleged theft across both schemes is put at about $17 million, though officials have not broken down Gerami’s exact dollar figure.
Neither defendant’s plea status has been made public, and the charges in available federal filings do not spell out maximum penalties. Those procedural details will surface in court, but the immediate message from prosecutors is clear: these are not bookkeeping errors. The government is treating these cases as deliberate schemes targeting federal benefits.
This Oregon action is a sliver of a much larger enforcement wave. Nationwide, 455 defendants, including 90 licensed medical professionals, face charges tied to more than $6.5 billion in alleged false claims. Administrative responses are sweeping: thousands of providers have had billing privileges suspended or revoked and inspectors general have carried out numerous exclusions and civil actions.
Centralized enforcement has been stepped up this year, a signal of shifting priorities in Washington. The appointment of Vice President Vance as fraud czar earlier this year reinforced that enforcement would be centralized and relentless. HHS-OIG has filed multiple actions under civil penalty laws seeking billions for the Medicare Trust Fund and pushed for civil settlements tied to a host of schemes.
Much of the coordination has flowed through the Department of Justice’s new National Fraud Enforcement Division, launched in April to align federal prosecutors, inspectors general, and regulators across jurisdictions. That centralized approach is exactly the kind of multiagency work credited with uncovering the Oregon schemes and others like them across the country. The crackdown treats fraud as theft from vulnerable Americans, not just a government accounting issue.
“Health care fraud inflates costs, restricts access to critical services, and siphons taxpayer dollars from senior citizens, people with disabilities, low-income families, veterans, and others who rely on these federal programs. Strong coordination among local, state, national, and international partners is essential to protecting the integrity of our health care system and ensuring those who exploit it are held accountable.”
The fraud allegations stretch beyond Medicare. Prosecutors say the defendants also targeted the Department of Health and Human Services, the Veterans Health Administration, and private insurers. That makes these cases especially relevant to veterans and others who depend on the reliability of benefit programs, and it adds a moral dimension to the fiscal one.
“Every dollar saved by investigating fraud helps ensure VA programs remain sustainable for the veterans who depend on them. The VA OIG is committed to investigating those who exploit VA programs and thanks the U.S. Attorney’s Office and Department of Health and Human Services Office of Inspector General for their collaboration to identify, investigate, and eliminate waste, fraud, and abuse.”
When the VA is billed for services that never happened, the loss is not an abstract number; it means fewer resources for veterans. Federal investigators stress that targeting these schemes preserves benefits for those who earned them, and that administrative actions—like exclusions and revocations—are part of a broader defense of program integrity. The DOJ and inspectors general are treating the problem as systemic.
Questions remain about how long such schemes can run and whether fraud-detection systems are catching what they should. A single lab allegedly moving $15 million in suspect billing should have triggered alarms, and investigators are looking at whether automated systems and private plans failed to flag red flags. That scrutiny will likely extend to CMS and Medicare Advantage plan oversight.
The broader enforcement picture shows the government using every tool at its disposal: criminal prosecutions, civil penalties, administrative exclusions, and revocation of controlled substance authorities. The point from a Republican perspective is simple—when fraud rises, the response should be forceful, centralized, and visible to deter others from gaming programs meant to help the sick, the elderly, and veterans.
These charges are now in the system; courts will sort the legal outcomes. For policymakers and prosecutors, the practical task is to tighten detection, close gaps that let sham clinics and fake results flourish, and make sure benefit programs actually serve the people they were created to help.
